Bristol Myers Squibb is nixing BeiGene’s Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame?

Bristol Myers Squibb is nixing BeiGene’s Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame?
aliu
Thu, 10/14/2021 – 09:34